How many deaths are linked to air pollution in the UK?

According to the Royal College of Physicians, around 30,000 deaths are linked to air pollution in the UK in 2025.

What health conditions are caused by toxic air?

Air pollution has been linked to cancer, heart disease, stroke, dementia, poor mental health, and issues in fetal development.

Is there a safe level of air pollution?

No. The Royal College of Physicians states that even low levels of air pollution can be harmful to health.

What actions are being recommended to combat toxic air?

Experts are urging the UK government to implement practical changes in transport, heating, and industry to reduce air pollution.

How much does air pollution cost the UK economy?

Air pollution costs the UK around £27 billion annually, with wider impacts possibly increasing this to £50 billion.

MHRA recalls Betahistine dihydrochloride tablets of Kent Pharmaceuticals

Home>
News>

        MHRA recalls Betahistine dihydrochloride tablets of Kent Pharmaceuticals
    
By Pb Staff writerNov 26, 2020
Pb Staff writer
 See Full Bio 
Hot Stories
AI Powered

        Urgent recall of contaminated batches of paracetamol
    

        Exclusive: Imaan Healthcare grows from 30 to 70 pharmacies in a year, Saghir Ahmed shares acquisition strategy
    
The Medicines and Health products Regulatory Agency (MHRA) has issued a drug recall for Betahistine dihydrochloride 8, 16mg tablets of Kent Pharmaceuticals Ltd.
Kent has informed that the following affected batches are contaminated with theophylline due to a cross-contamination issue identified with an excipient that was used in the manufacture of the finished product.
Product details
Betahistine dihydrochloride 8mg Tablets PL 30464/0019Betahistine dihydrochloride 16mg Tablets PL 30464/0020
ProductBatch NumberExpiry DatePack SizeFirst Distributed
Betahistine dihydrochloride 8mg TabletsEC1061901/10/20228421/10/2020
EC1071901/10/20228409/09/2020
EC1081901/10/20228404/05/2020
Betahistine dihydrochloride 16mg TabletsGY1111901/10/20228421/04/2020
GY1121901/10/20228405/05/2020
GY1131901/10/20228423/09/2020
 
Healthcare professionals have been advised to immediately stop supplying the batches and quarantine and return all the stock to their supplier using approved process.
Related News
News
        Pensions Ombudsman probing Boots pension dispute
    
Shajil Kumar
10h
News
        UK watchdog fines 23andMe £2.31m for data breach
    
Shajil Kumar
11h
News
        Community pharmacy voices need to be ‘heard really loud’, new NPA chief tells Pharmacy Business
    
Sarwar Alam
13h
News
        NHS rejects Alzheimer's drugs shown to delay early-stage of disease
    
Sarwar Alam
13h

More For You
A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

        iStock
    

        Royal College of Physicians paints grim picture of air pollution in UK
    
Shajil Kumar
Jun 19, 2025
Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.
The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.
Keep ReadingShow less
Most Popular
News
        Pharma industry group unhappy with NHS drug pricing offer
    
Sarwar Alam
11 June
News
        Mounjaro rollout: GPs urge patients not to ask for jabs
    
Shajil Kumar
18 June
News
        Weight-loss injections can cause gallstones, warns pharmacist
    
Longjam Dineshwori
17 March
News
        Government taking steps to mitigate shortage of cancer drug Creon
    
Sarwar Alam
11 June
News
        Hay fever treatment: First OTC combination nasal spray launched
    
Longjam Dineshwori
24 April
News
        RPS announces new director of England
    
Sarwar Alam
16 June
Don’t Miss Out
Get the latest updates and insights delivered to your inbox.
Enter your email
By subscribing, you agree to our Terms & Conditions.
View Terms & Conditions
×Terms and Conditions

        By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
        partners/sponsors sharing promotional product information via email and print communication from Asian Trade
        Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
        unsubscribe link in our emails. We will use your email address to personalize our communications and send you
        relevant offers. Your data will be stored up to 30 days after unsubscribing.
        

        Contact us at
        data@amg.biz
        to see how we manage and store your data.
      
The last date for submission is 30 June 2025.

        Pic credit: iStock
    

        Community pharmacies falling behind on data security toolkit submissions
    
Lakshmi Prabha
Jun 19, 2025
More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.
Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.
Keep ReadingShow less
In the UK, over three million people have osteoporosis.

        Pic credit: iStock
    

        Digital guide launched to help patients with osteoporosis
    
Sarwar Alam
Jun 19, 2025
The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.
After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication. 
Keep ReadingShow less
GPhC's Strategic Plan 2025-30 will focus on empowering pharmacists and pharmacy technicians.

        iStock
    

        GPhC five-year plan to empower pharmacists, uphold public trust
    
Shajil Kumar
Jun 19, 2025
The General Pharmaceutical Council (GPhC) launched its new plan for the next five years to uphold safety, quality and public trust in pharmacy.
The regulatory body unveiled its Strategic Plan 2025-30 during a Parliamentary event attended by pharmacy minister Stephen Kinnock on Wednesday (18).
Keep ReadingShow less
Medical device manufacturers will have to monitor the safety and performance of their products already in use.

        iStock
    

        Medical device regulation overhauled to improve patients' safety
    
Shajil Kumar
Jun 19, 2025
Medical device manufacturers must now adhere to the UK's post-market surveillance (PMS) regulations.
The new rule came into effect on June 16, and manufacturers will have to monitor the safety and performance of their products already in use.
Keep ReadingShow less
Load More

Site Navigation

MHRA recalls Betahistine dihydrochloride tablets of Kent Pharmaceuticals

Urgent recall of contaminated batches of paracetamol

Exclusive: Imaan Healthcare grows from 30 to 70 pharmacies in a year, Saghir Ahmed shares acquisition strategy

Related News

Pensions Ombudsman probing Boots pension dispute

Community pharmacy voices need to be ‘heard really loud’, new NPA chief tells Pharmacy Business

NHS rejects Alzheimer's drugs shown to delay early-stage of disease

Amish Patel receives BEM in King's Birthday Honours List

Locums should stand up for their interests, say 'no' to unfair terms: PDA

Type 2 diabetes treatment: Novo Nordisk discontinues Victoza amid ongoing drug shortages

B&S Group mourns the death of Ketan Shah in Air India crash

Potential Side Effects of Mounjaro [What You Need to Know]

More For You

Royal College of Physicians paints grim picture of air pollution in UK

Most Popular

Pharma industry group unhappy with NHS drug pricing offer

Mounjaro rollout: GPs urge patients not to ask for jabs

Weight-loss injections can cause gallstones, warns pharmacist

Government taking steps to mitigate shortage of cancer drug Creon

Hay fever treatment: First OTC combination nasal spray launched

RPS announces new director of England

Digital guide launched to help patients with osteoporosis

GPhC five-year plan to empower pharmacists, uphold public trust

Medical device regulation overhauled to improve patients' safety

Product	Batch Number	Expiry Date	Pack Size	First Distributed
Betahistine dihydrochloride 8mg Tablets	EC10619	01/10/2022	84	21/10/2020
	EC10719	01/10/2022	84	09/09/2020
	EC10819	01/10/2022	84	04/05/2020
Betahistine dihydrochloride 16mg Tablets	GY11119	01/10/2022	84	21/04/2020
	GY11219	01/10/2022	84	05/05/2020
	GY11319	01/10/2022	84	23/09/2020

Latest Stories

Start your day right!

MHRA recalls Betahistine dihydrochloride tablets of Kent Pharmaceuticals

Related News

More For You

Most Popular

Don’t Miss Out